PDX INSIGHTS
PIONEERING CANCER RESEARCH
Home
Collections
Bladder
Breast
Leukemia
Liver
Pancreas
Sarcoma
Omics Tools
Management
Data Management
File Management
Publications
Contact Us
Log In
You need to enable JavaScript to run this app page.
Pancreas
BCM-PDAC-2
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-PDAC-2
Contact Model Developer
Model Contact
Model: BCM-PDAC-2
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email:
qizhiyao@bcm.edu
Patient Information
Clinical Timeline
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-PDAC-2
Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 50
F
P
1
2
3
4
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AKAP9
chr7
92022864
92022864
A
AAAC
c.4004_4006dup
aaa/aAACaa
p.K1335_L1336insQ
0.956
15
13
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000356239.8
COSV62337888
rs10644111
15
13
ENST00000356239.8
COSV62337888
rs10644111
AR
chrX
67545316
67545316
T
TGCAGCA
c.234_239dup
ctg/ctGCAGCAg
p.Q79_Q80dup
0.656
17
2
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000374690.9
COSV65953707
17
2
ENST00000374690.9
COSV65953707
AR
chrX
67546514
67546523
TGGCGGCGGC
T
c.1412_1420del
GGCGGCGGC/-
p.G471_G473del
0.896
17
3
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000374690.9
COSV65963320
17
3
ENST00000374690.9
COSV65963320
ARHGAP5
chr14
32093338
32093338
A
AT
c.2676dup
gat/gaTt
p.E893*
0.458
2
2
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000345122.8
COSV61535007
2
2
ENST00000345122.8
COSV61535007
ARID1A
chr1
26729817
26729818
AG
A
c.1307del
caG/ca
p.G436Afs*183
0.95
12
2
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000324856.13
12
2
ENST00000324856.13
ATM
chr11
108254034
108254034
T
C
c.2119T>C
Tct/Cct
p.S707P
0.501
12
4
Missense Variant
Missense Variant
MODERATE
ENST00000278616.8
Benign/Likely_benign
COSV53743430
0.007819920000
rs4986761
12
4
ENST00000278616.8
Benign/Likely_benign
COSV53743430
rs4986761
ATR
chr3
142469495
142469495
A
C
c.6394T>G
Tat/Gat
p.Y2132D
0.954
2
2
Missense Variant
Missense Variant
MODERATE
ENST00000350721.9
Benign/Likely_benign
COSV63384218
0.003051310000
rs28910273
2
2
ENST00000350721.9
Benign/Likely_benign
COSV63384218
rs28910273
ATR
chr3
142542712
142542712
T
TA
c.3402dup
-/T
p.N1135*
0.37
2
2
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000350721.9
COSV63394761
2
2
ENST00000350721.9
COSV63394761
ATRX
chrX
77682471
77682471
C
G
c.2785G>C
Gag/Cag
p.E929Q
0.929
20
20
Missense Variant
Missense Variant
MODERATE
ENST00000373344.10
Benign
rs3088074
20
20
ENST00000373344.10
Benign
rs3088074
BRIP1
chr17
61857081
61857081
T
C
c.356A>G
aAt/aGt
p.N119S
0.564
3
2
Missense Variant
Missense Variant
MODERATE
ENST00000259008.7
Uncertain_significance
rs889877039
3
2
ENST00000259008.7
Uncertain_significance
rs889877039
BUB1B
chr15
40220700
40220700
A
C
c.3094A>C
Aac/Cac
p.N1032H
0.989
2
2
Missense Variant
Missense Variant
MODERATE
ENST00000287598.11
Conflicting_interpretations_of_pathogenicity
COSV55010127
0.000709004000
rs34700927
2
2
ENST00000287598.11
Conflicting_interpretations_of_pathogenicity
COSV55010127
rs34700927
CACNA1D
chr3
53769994
53769994
C
T
c.3892C>T
Cct/Tct
p.P1298S
0.408
2
2
Missense Variant
Missense Variant
MODERATE
ENST00000350061.11
Benign
COSV55448703
0.005195230000
rs72556360
2
2
ENST00000350061.11
Benign
COSV55448703
rs72556360
CCDC6
chr10
59793004
59793004
C
CGGAGGT
c.1332_1337dup
ccg/ccACCTCCg
p.P447_P448dup
0.433
2
2
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000263102.7
COSV54054274
rs575393361
2
2
ENST00000263102.7
COSV54054274
rs575393361
CDH1
chr16
68813337
68813337
G
A
c.1162G>A
Gag/Aag
p.E388K
0.457
2
2
Missense Variant
Missense Variant
MODERATE
ENST00000261769.10
Benign
COSV55730651
0.000025322900
rs372838203
2
2
ENST00000261769.10
Benign
COSV55730651
rs372838203
CIITA
chr16
10909070
10909070
A
G
c.2702A>G
cAg/cGg
p.Q901R
0.989
24
24
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
0.983235000000
rs7197779
24
24
ENST00000618327.4
Benign
rs7197779
Total mutations showing: 50
F
P
1
2
3
4
N
E
Rows Per Page
10
15
25
50
Download
CNV
Histology Information for Model: BCM-PDAC-2
Patient
PDX
Metastasis Information for Model: BCM-PDAC-2
Patient
PDX
Liver
Local recurrence
Lung
Rectum
lymph node
Patient Treatment Information for Model: BCM-PDAC-2
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
10
chemo/radiation (unknown specific drug name)
Adjuvant
88.79
89.46
245 days
Not Reported
Unknown
Disease progression and clinical decompensation
Please wait...